Simplex Trading
IMMX icon

Simplex Trading’s Immix Biopharma IMMX Stock Holding History

Simplex Trading’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,800
Closed -$40.8K – 9566
2025
Q4 		$40.8K Buy
+7,800
New +$32.1K ﹤0.01% 5846

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Simplex Trading's IMMX Position: Q1 2026 in Review

Simplex Trading opened a new position in Immix Biopharma (IMMX) in Q1 2026: 4,255 shares worth $38.8K. The stake represents ﹤0.01% of the portfolio and ranks #6132 among its holdings. This is a return to the name: Simplex Trading previously reported a position in IMMX as recently as Q4 2024.

Simplex Trading first reported a position in IMMX in Q1 2024 and has held it in 4 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Simplex Trading held 4,255 shares of Immix Biopharma worth $38.8K as of Q1 2026.
  • Immix Biopharma was a new Simplex Trading position in Q1 2026.
  • Immix Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6132 holding.
  • Simplex Trading first reported a position in Immix Biopharma in Q1 2024 and has held it in 4 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.